ARHP launches Depo-Provera education program.
Kaunitz
A
A
D000554:Ambulatory Care Facilities; D000569:Americas; D003142:Communication; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003376:Counseling; D003695:Delivery of Health Care; D019049:Developed Countries; D004493:Education; D005193:Family Planning Services; D006262:Health; D006282:Health Personnel; D006285:Health Planning; D008402:Mass Media; D017258:Medroxyprogesterone Acetate; D009656:North America; D009726:Nurses; D009934:Organization and Administration; D010174:Pamphlets; D010820:Physicians; D012736:Sex Education; D013637:Tape Recording; D013664:Teaching Materials; D014481:United States; D014743:Videotape Recording
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
Americas; Clinic Activities; Communication; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Counseling; Delivery Of Health Care; Depo-provera; Developed Countries; Education; Family Planning; Family Planning Education; Health; Health Personnel; Mass Media; Medroxyprogesterone Acetate; North America; Northern America; Nurses; Organization And Administration; Pamphlets; Physicians; Printed Media; Program Activities; Programs; Tape Recordings; Teaching Materials; United States; Videotapes